Timothy Coughlin, Director at Travere Therapeutics, holds 56.25K shares in Travere Therapeutics (Ticker: TVTX), holds 16.00K shares in Vir Biotechnology (Ticker: VIR), holds 72.40K shares in ADC Therapeutics (Ticker: ADCT).
Timothy Coughlin latest transaction was an Uninformative Buy of $265.20K.
What was Timothy Coughlin's most profitable transaction?
Timothy Coughlin’s most profitable transaction was an Informative Buy of ATYR stock on June 3, 2024. The return on the trade was 191.30%.
What is Timothy Coughlin's role in Travere Therapeutics?
Timothy Coughlin's role in Travere Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.